Breeze Meds vs MEDVi: Which GLP-1 Provider Is Better?
A side-by-side comparison of Breeze Meds and MEDVi covering pricing, scores, medication types, insurance, and more to help you decide.
Breeze Meds
#31 of 317.3/10
Compounded GLP-1 provider focused on fast shipping and a no-fuss enrollment process.
Visit Breeze MedsHigher Rated
MEDVi
#9 of 318.3/10
Compounded GLP-1 platform offering both oral and injectable options with flexible dosing and affordable pricing.
Visit MEDVi| Feature | Breeze Meds | MEDVi |
|---|---|---|
| Our Score | 7.3/10 | 8.3/10 |
| Starting Price | $189/mo | $179/mo |
| Medication Type | Compounded | Compounded |
| Insurance Accepted | No | No |
| Best For | Users who want a straightforward compounded GLP-1 program with fast shipping | Users who want a low entry price with oral and injectable compounded options |
| Ranking | #31 | #9 |
Pros & Cons Compared
Breeze Meds
Pros
- +Fast shipping
- +Simple enrollment
- +Competitive pricing
- +No fuss approach
Cons
- −Compounded only
- −Less comprehensive support
MEDVi
Pros
- +One of the few compounded providers offering both oral tablets and injectable semaglutide
- +Micro-dosing options available — can start at sub-standard doses for patients concerned about side effects
- +Sleek onboarding experience with clear progress tracking through their patient portal
- +$179/mo is competitive for a platform with both oral and injectable compounded formulations
Cons
- −Compounded medications only — no path to brand-name Wegovy or Zepbound through their platform
- −No insurance accepted, and oral compounded semaglutide has less clinical data than injectable forms
Our Verdict
MEDVi edges out Breeze Meds with a score of 8.3/10 vs 7.3/10. If budget is your priority, MEDVi starts at $179/mo compared to Breeze Meds's $189/mo. Choose Breeze Meds if you want: users who want a straightforward compounded glp-1 program with fast shipping. Choose MEDVi if you want: users who want a low entry price with oral and injectable compounded options.